Immunogenic targets in non-small cell lung cancer: more is more.

@article{Gnjatic2005ImmunogenicTI,
  title={Immunogenic targets in non-small cell lung cancer: more is more.},
  author={Sacha Gnjatic},
  journal={Clinical cancer research : an official journal of the American Association for Cancer Research},
  year={2005},
  volume={11 15},
  pages={5331-2}
}
  • Sacha Gnjatic
  • Published 2005 in
    Clinical cancer research : an official journal of…
Reports of human clinical trials aiming at antigen-specific induction of T cell and antibody responses against non– small cell lung cancers (NSCLC) have started to surface within the last 5 years (1–11). In a large proportion of trials, the nature of the antigen(s) has not been precisely determined, as in the case of vaccines with tumor cells or cell extracts and granulocyte macrophage colony-stimulating factors or dendritic cells as adjuvant, making the evaluation of successful immunogenicity… CONTINUE READING